Market-watcher sees double-digit growth for disposables; CMO will refurbish factory bought from Pfizer;

> High Tech Business Decisions says it expects the market for single-use systems to grow at double-digit rates, with similar growth rates for disposables supporting both upstream and downstream bioprocesses. Article (sub. req.)

> European contract manufacturer Fareva plans to continue operating the factory in Henrico, VA, it's buying from Pfizer ($PFE) and invest $42 million. Story

> Twin-screw extrusion, a process common in the plastics industry, is being studied at Bradford University for use in making co-crystals, which offer an alternative means of creating targeted soluble drug compounds. Story

> GLP- and GMP-compliant contract lab Advantar, which provides analytical and formulation development services, has entered a non-exclusive strategic alliance with DavosPharma, provider of chemistry and pharma development management solutions. Item

> Big 3 Distributor AmerisourceBergen ($ABC) has acquired Premier Source, a reimbursement consultancy to medical device, pharma, molecular diagnostic and biotechnology manufacturers. AmericasourceBergen release

> Generic drugmakers must ensure their products follow the same scoring practices as references drugs. Draft guidance

> Pfizer says it has signed a 10-year lease with the Massachusetts Institute of Technology (MIT) for more than 180,000 square feet in a new building under development in Cambridge, MA, for cardiovascular R&D. Story

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.